The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MDM2 309 single nucleotide polymorphisms (SNP) and clinical outcome in patients with advanced squamous cell carcinoma of head and neck (SCCHN).
M. Gasco
No relevant relationships to disclose
D. Vivenza
No relevant relationships to disclose
M. Monteverde
No relevant relationships to disclose
L. Lattanzio
No relevant relationships to disclose
I. Colantonio
No relevant relationships to disclose
G. Natoli
No relevant relationships to disclose
E. Miraglio
No relevant relationships to disclose
A. Comino
No relevant relationships to disclose
N. Syed
No relevant relationships to disclose
T. Crook
No relevant relationships to disclose
M. C. Merlano
No relevant relationships to disclose
C. Lo Nigro
No relevant relationships to disclose